Blenoxane (Bleomycin) for Lymphoma

Overview

Blenoxane is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating Hodgkin lymphoma and non-Hodgkin lymphoma. Blenoxane is often combined with other drugs such as doxorubicin (also known as hydroxydaunorubicin and sold as Adriamycin), vinblastine sulfate, and corticosteroids in specific chemotherapy regimens. Blenoxane is also known by its drug name, bleomycin. Blenoxane is an anticancer drug used in chemotherapy. Blenoxane is a member of a drug class called antitumor antibiotics. Blenoxane is believed to work by interfering with DNA synthesis and blocking cell division in several ways.

How do I take it?

Blenoxane is usually administered as an intravenous infusion during chemotherapy treatment.

Side effects

The FDA-approved label for Blenoxane lists common side effects including fever, chills, nausea, vomiting, weight loss, hair loss, mouth sores, changes to the nails, and skin reactions such as color changes, peeling, stretch marks, and sores. Rare but serious side effects listed for Blenoxane include allergic reactions, lung conditions such as pneumonitis or pulmonary fibrosis, and changes to the cardiovascular system that raise the risk for stroke or heart attack.

For more details about this treatment, visit:

Blenoxane — Chemocare

Chemotherapy for Hodgkin Lymphoma — American Cancer Society

Chemotherapy for Non-Hodgkin Lymphoma — American Cancer Society